Allergan, Inc. (NYSE:AGN) Investor Alert: Investigation of Buyout Bid by Valeant Pharmaceuticals International
An investigation on behalf of investors, who currently hold shares of Allergan, Inc. (NYSE:AGN) shares, was announced concerning whether the takeover of Allergan, Inc. by Valeant Pharmaceuticals International for a value of approximately $152.88 per share is unfair to NYSE:AGN stockholders.
View full press release